NASDAQ · COCH
Envoy Medical, Inc.
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
Loading market information…
NASDAQ · NIVF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NewGenIvf Group Limited’s quoted price sits in the lower half of its reported 52-week range, 99.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
NewGenIvf Group Limited’s next earnings report is currently expected on Mar 3, 2027, with estimated earnings per share of $783.36. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow NewGenIvf Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$6.50-$0.16 (-2.4%)
Envoy Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
$1.82-$0.09 (-4.71%)
SCWorx Corp.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
$0.68-$0.01 (-1.31%)
PetVivo Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 54.67% below the high.
$0.54-$0.02 (-3.6%)
INVO Fertility, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.98% below the high.
$0.14-$0.01 (-6.67%)
Hepion Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 36.36% below the high.
$3.66-$0.19 (-4.94%)
Concord Medical Services Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.18% below the high.
$0.11$0.00 (0.0%)
Longevity Health Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.41% below the high.
$0.08-$0.01 (-7.23%)
CDT Equity Inc.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
